Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PROTAC RIPK degrader-6

😃Good
Catalog No. T36243Cas No. 2089205-64-9

PROTAC RIPK degrader-6 (example 1) is a PROTAC engineered for RIP Kinase degradation, comprising a RIP2 kinase inhibitor linked to a cereblon binder[1].

PROTAC RIPK degrader-6

PROTAC RIPK degrader-6

😃Good
Catalog No. T36243Cas No. 2089205-64-9
PROTAC RIPK degrader-6 (example 1) is a PROTAC engineered for RIP Kinase degradation, comprising a RIP2 kinase inhibitor linked to a cereblon binder[1].
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$898InquiryInquiry
10 mg$1,285InquiryInquiry
25 mg$2,100InquiryInquiry
1 mL x 10 mM (in DMSO)$770InquiryInquiry
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
PROTAC RIPK degrader-6 (example 1) is a PROTAC engineered for RIP Kinase degradation, comprising a RIP2 kinase inhibitor linked to a cereblon binder[1].
In vitro
PROTACs facilitate the targeted degradation of proteins and polypeptides by binding to cereblon at one end and the target protein (RIP2 kinase) at the other, thereby bringing the target protein close to the E3-Ligase. This interaction forms a ternary complex that results in the polyubiquitination and subsequent degradation of the target protein[1].
Chemical Properties
Molecular Weight889.01
FormulaC43H48N6O11S2
Cas No.2089205-64-9
SmilesCC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ccnc2cc1OCCOCCOCCOCCOCC(=O)Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 100 mg/mL (112.48 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 5 mg/mL (5.62 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.1248 mL5.6242 mL11.2485 mL56.2423 mL
5 mM0.2250 mL1.1248 mL2.2497 mL11.2485 mL
10 mM0.1125 mL0.5624 mL1.1248 mL5.6242 mL
20 mM0.0562 mL0.2812 mL0.5624 mL2.8121 mL
50 mM0.0225 mL0.1125 mL0.2250 mL1.1248 mL
100 mM0.0112 mL0.0562 mL0.1125 mL0.5624 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PROTAC RIPK degrader-6 | purchase PROTAC RIPK degrader-6 | PROTAC RIPK degrader-6 cost | order PROTAC RIPK degrader-6 | PROTAC RIPK degrader-6 chemical structure | PROTAC RIPK degrader-6 in vitro | PROTAC RIPK degrader-6 formula | PROTAC RIPK degrader-6 molecular weight